TMEM173, hsa-miR (-611 and -1976) and RP4-605O3.4 showed a significant difference in their expression (Table S6), which makes the use of these insulin resistance associated biomarkers together with HOMA-IR possible in differentiating insulin resistant from insulin sensitive patients. This evidence concerns the gene INS and Insulin resistance.